Heron Therapeutics (HRTX) Stock: Buy, Sell, or Hold?
HRTX - Heron Therapeutics, Inc.
$0.30
0.00 (0.27%)
▲
5d:
-14.95%
30d:
+3.32%
90d:
-38.91%
WAIT
LOW Confidence
Analysis Updated: Oct 27, 2026 12:00 AM ET
Earnings: Nov 03, 2026
5d
Get Alerted When HRTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: HRTX is down 15.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: HRTX is down 15.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: HRTX is currently trading at $0.30, which is considered slightly low relative to its 30-day fair value range of $0.30 to $0.37. From a valuation perspective, the stock is trading at a discount (Forward PE: -2.7) compared to its historical average (1.9). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HRTX is in a strong downtrend. Immediate support is located at $0.28, while resistance sits at $0.40.
Market Sentiment: HRTX scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.00 (+2221.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HRTX is in a strong downtrend. Immediate support is located at $0.28, while resistance sits at $0.40.
Market Sentiment: HRTX scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.00 (+2221.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.30 -
$0.37
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 2221.7% below Wall St target ($7.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.30 -
$0.37
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.28
Resistance Level
$0.40
Current Trend
Strong Downtrend
Technical data as of
Oct 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.74
Wall Street Target
$7.00
(+2221.7%)
Revenue Growth (YoY)
1.3%
Profit Margin
-22.5%
PE vs Historical
-2.7 vs 1.9
CHEAP
Share & Embed Analysis
Last updated: October 28, 2026 2:20 AM ET
Data refreshes hourly during market hours. Next update: 3:20 AM
Data refreshes hourly during market hours. Next update: 3:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HRTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
25 analysts |
$1144 | 56 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$139 | 47 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
17 analysts |
$141 | 64 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 54 HOLD |
|
CLYM
Climb Bio Inc |
STRONG BUY
16 analysts |
$28 | 51 HOLD |
